Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002434
Accepted
2024-08-07 00:15:15
Documents
1
Effectiveness Date
2024-08-06
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 580
  Complete submission text file 9999999995-24-002434.txt   1916
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: EFFECT | Act: 33 | File No.: 333-280680 | Film No.: 241181243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)